METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease
N6-methyladenosine (m6A) mRNA modification plays critical roles in various biological events and is involved in multiple complex diseases. However, the role of m6A modification in autophagy in nonalcoholic fatty liver disease (NAFLD) remains largely unknown. Here, we report that m6A modification was...
Saved in:
Published in | Molecular therapy Vol. 30; no. 2; pp. 932 - 946 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
02.02.2022
American Society of Gene & Cell Therapy |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!